PULM
Pulmatrix, Inc.
$1.73
+0.00 (+0.00%)
At close · Jul 7
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Management believes that, given the Company’s current cash position and forecasted negative cash flows from operating activities over the next twelve months, there is substantial doubt about its ability to continue as a going concern after the date that is one year from the date that these financial statements are issued without the closing of the Merger.”View the 10-Q filed May 15, 2026
Market Cap
$6.32M
Shares
3,652,285
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.73
Open$1.76
Day$1.68–1.78
52W$1.16–6.96
Avg vol 30d83K
Short int10K · 0.3% float · 1.0d
Short vol7%
Last earningsMay 15, 2026
DataJan 2020–Jul 2026
Filing10-Q · May 15
Equibles Rating
blended score · not investment advice
Overall
Buy
Technical · trend & momentum
Sell
◦
50 / 200-day cross
no cross
−
Price vs 200-day avg
−38% below
+
Price vs 50-day avg
+23% above
−
RSI (14)
71 · overbought
+
MACD trend
positive
−
52-week position
10% · near low
Sentiment · smart money
Bullish
◦
Trend (MA cross)
50d $1 › 200d $3 — 200d above 50d
◦
Institutional flow
0% holders QoQ · +5 funds added
◦
Insider flow
No net insider activity over 90 days
+
Short interest
0.27% of float · ▼ -59.9% MoM · 1.0 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
15 holders — mid 3-yr range
Fundamentals
Strong
+
Revenue growth
+5070% Y/Y
+
EPS growth
+46% Y/Y
−
Free cash flow
$-5.8M
+
Balance sheet
net cash $4.1M
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
Next earnings call
Aug 29, 2026
Est · unconfirmed
· in 7 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 15, 2026
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
−38% below
Bearish
Price vs 50-day avg
+23% above
Bullish
RSI (14)
71 · overbought
Bearish
MACD trend
positive
Bullish
52-week position
10% · near low
Bearish
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross)
No cross
50d $1 › 200d $3 — 200d above 50d
Institutional flow
Flat
0% holders QoQ · +5 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.27% of float · ▼ -59.9% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
15 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $1
Now $2 · 10%
52-wk high $7
vs 200-day avg -38%
vs 50-day avg +23%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
PULM
this stock
Pulmatrix, Inc.
|
$6.32M | -22.4% | -54.3% | — | 0.3% |
|
ONC
BeOne Medicines Ltd.
|
$488.96B | +1.9% | +22179.2% | 995.1 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$132.55B | +15.2% | +46.2% | 31.0 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$70.90B | -12.3% | +20.8% | 16.5 | 3.2% |
|
ARGX
Argenx SE
|
$57.49B | +9.4% | — | — | 2.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| PULM | +6.1% | +30.1% | -26.4% | +1.8% | -22.4% |
| SPY | +0.9% | +1.4% | +7.6% | +0.1% | +9.7% |
| vs SPY | +5.2% | +28.7% | -33.9% | +1.6% | -32.1% |